Vorumotide
Vorumotide is an immunological agent for active immunization as well as an antineoplastic agent[1].
Product Specifications
CAS Number
935395-34-9
UNSPSC
12352209
Target
Others
Type
Peptides
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vorumotide.html
Solubility
10 mM in DMSO
Smiles
OC(C=C1)=CC=C1C[C@H](NC([C@H](CCCNC(N)=N)NC([C@H](CCCCN)NC([C@H](CC(N)=O)NC([C@H](CS)NC(CNC([C@@H]2CCCN2)=O)=O)=O)=O)=O)=O)C(N[C@H](C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCSC)C(N[C@H](C(N[C@@H](CO)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@@H]([C@H](O)C)C(NCC(O)=O)=O)=O)CC3=CN=CN3)=O)=O)=O)=O)CC4=CN=CN4)=O)=O)=O)=O)CC5=CN=CN5)=O)=O)=O)=O)CC6=CC=CC=C6)=O
Molecular Formula
C114H181N39O29S2
Molecular Weight
2626.03
References & Citations
[1]WHO Drug Informat ion - World Health Organization (WHO) .|[2]WHO Drug Information-World Health Organization (WHO) .
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL505815V 500 µL Each
Chrnb3 Mouse shRNA Lentiviral Particle (Locus ID 108043)
Sign In for Pricing
View Details bs-5742R-PE-Cy7 100 µL
Phospho-MARK2 (Ser595) Polyclonal Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details 